Task: Answer the following question about the molecule with SMILES O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Phase 2 Clinical Trials
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1
O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1
1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.